Rapport Therapeutics, Inc.
RAPP$475M
Small CapNASDAQPharmaceutical Preparations🇺🇸North AmericaBOSTON69 employees
Drugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Oct 15, 2026
30wMarket Overview
Stock performance and key metrics
RAPP News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
RAP-219 | Phase 2 | Focal Onset Seizures | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply